<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XI-IATI-WBTF-P167064</iati-identifier>
  <reporting-org ref="XI-IATI-WBTF" type="40">
   <narrative xml:lang="EN">World Bank Trust Funds</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">HIV Vaccine Research and Development</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">To develop and characterize viable HIV vaccine candidate(s) and other potential viral vectors as basic research for new technologies  against infectious diseases of poverty.</narrative>
  </description>
  <participating-org ref="TF073106" role="4" type="40">
   <narrative xml:lang="EN">HIV Vaccine Research and Development Trust Fund</narrative>
  </participating-org>
  <participating-org ref="TF513001" role="1" type="10">
   <narrative xml:lang="EN">Japan - Ministry of Finance</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-02-01" type="1"></activity-date>
  <activity-date iso-date="2019-02-01" type="2"></activity-date>
  <activity-date iso-date="2021-12-31" type="3"></activity-date>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN"></narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN"></narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Mr Robert Oelrichs</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Health Specialist</narrative>
   </job-title>
   <telephone>1202-458-7916</telephone>
   <email>roelrichs@worldbank.org</email>
   <mailing-address>
    <narrative xml:lang="EN">1818 H St, NW, Washington DC - 22036</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region percentage="100" vocabulary="1">
   <narrative xml:lang="EN"></narrative>
  </recipient-region>
  <sector code="12250" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">+![cdata[Infectious disease control]]+</narrative>
  </sector>
  <collaboration-type code="2"></collaboration-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2019-02-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-06-30">5752381</value>
  </budget>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">1409859.49</value>
   <description>
    <narrative xml:lang="EN">Disbursement(Recipient-Executed Trust Funds Disbursements ) -  for June , 2021</narrative>
   </description>
   <provider-org provider-activity-id="XI-IATI-WBTF">
    <narrative xml:lang="EN">World Bank Trust Funds</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XI-IATI-WBTF-P167064">
    <narrative xml:lang="EN"></narrative>
   </receiver-org>
   <finance-type code="110"></finance-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">408836.94</value>
   <description>
    <narrative xml:lang="EN">Disbursement(Recipient-Executed Trust Funds Disbursements ) -  for September , 2020</narrative>
   </description>
   <provider-org provider-activity-id="XI-IATI-WBTF">
    <narrative xml:lang="EN">World Bank Trust Funds</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XI-IATI-WBTF-P167064">
    <narrative xml:lang="EN"></narrative>
   </receiver-org>
   <finance-type code="110"></finance-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">2531110.8</value>
   <description>
    <narrative xml:lang="EN">Disbursement(Total Recipient-Executed Trust Funds Disbursements )-as of June 30th, 2020</narrative>
   </description>
   <provider-org provider-activity-id="XI-IATI-WBTF">
    <narrative xml:lang="EN">World Bank Trust Funds</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XI-IATI-WBTF-P167064">
    <narrative xml:lang="EN"></narrative>
   </receiver-org>
   <finance-type code="110"></finance-type>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">5752381</value>
   <description>
    <narrative xml:lang="EN">Incoming Commitment (Total Grant Allocated Amount)-as of June 30th, 2020</narrative>
   </description>
   <provider-org provider-activity-id="XI-IATI-WBTF-TF073106">
    <narrative xml:lang="EN">HIV Vaccine Research and Development Trust Fund</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="P167064">
    <narrative xml:lang="EN">Bilateral, unspecified</narrative>
   </receiver-org>
   <finance-type code="110"></finance-type>
  </transaction>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/167721582928569801/pdf/Disclosable-Version-of-the-ISR-HIV-Vaccine-Research-and-Development-P167064-Sequence-No-03.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Status and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/421381572899005436/pdf/Disclosable-Version-of-the-ISR-HIV-Vaccine-Research-and-Development-P167064-Sequence-No-02.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Status and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/455891556305493133/pdf/Disclosable-Version-of-the-ISR-HIV-Vaccine-Research-and-Development-P167064-Sequence-No-01.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Status and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/663221607877548793/pdf/Disclosable-Version-of-the-ISR-HIV-Vaccine-Research-and-Development-P167064-Sequence-No-04.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Status and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.worldbank.org/projects/P167064?lang=en">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Project URL</narrative>
   </title>
   <category code="A12"></category>
  </document-link>
  <related-activity ref="XI-IATI-WBTF-TF073106" type="1"></related-activity>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1.b  Advanced characterization of Env-specific serum antibodies induced by vaccination completed incl. epitope specificity determination by binding and competition assays &amp; evaluation of effects</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1.c  Analysis of blood transcriptomic profiles at select time points after vaccination completed and how vaccination affects modular gene sets such as those connected to B- and T-cell responses etc.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.2.c A GMP compliant cell line of for use in GMP manufacturing of VSV based HIV vaccine vectors produced, if the pseudotyping cellline has been demonstrated to be feasible.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.3.d If appropriate based on result from 3.a and 3.c,  (up to) two new vector backbone (HIV.Env) candidates selected for use in vaccine development used to product material comparable to the research</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.Joint learning events and meeting outputs developed with global partners in vaccine R&amp;D for potential epidemic diseases and diseases of poverty</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.a Joint meetings to reach out to potential global partners organized three times.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.b Communication material for global partners developed.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.c Field visit(s) by potential global partners organized.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1.a  Primary sample analysis, antibody titers (Elisa) and T-cell from animals immunized with the VSV&#x2206;G-Env vector completed.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.2.a  Technical feasibility of two approaches to producing a VSV G pseudotyping cell including: G expression following extended cell passage and ability to propagate VSV&#x2206;G-Env vector determined.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.3.a  A VSV(NJ)&#x2206;G-Env vector shown to have replicative capacity equivalent to the original VSV&#x2206;G-Env counterpart based on VSV(IND)constructed.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.3.b  A second vector platform for further evaluation &amp; development from among, but not limited to VSVlike viruses (Cocal, Carajas, Maraba) or other more immunologically distant relatives identified</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.2.b Technical feasibility of ( a)DNA expression construct encoding alternative G glycoprotein less cytotoxic (b)DNA expression construct encoding alternative viral glycoprotein &amp; supports VSV pseudo</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1 VSV-&#x2206;G (HIV.Env) vector fully characterized including in immunological, genetic and cellular propagation aspects</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1.d  Analysis of samples collected from animals from study IAVI#1601 and 3-4 small pilot studies conducted to specifically quantify and compare cytokines and chemokines induced by vaccination</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.2.Two further novel vectors (VSV(NJ) and a novel VSV-like vector) constructed and characterized</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.3.GMP compliant cell line for use in manufacturing of VSV-based HIV vaccine vectors produced</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.3.c In addition to VSV(NJ), a second new vector developed and characterized based on an immunologically distant VSV-like virus tobe determined after database sequence comparison.</narrative>
    </title>
    <baseline iso-date="2018-10-01" value="No" year="2018">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
